Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00258544 · ClinicalTrials.gov registry record
Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)
A clinical trial of Pulmonary Fibrosis, sponsored by University of Pittsburgh.
- Active
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT00258544: Active study of Pulmonary Fibrosis, sponsored by University of Pittsburgh.
NCT00258544 is a study of Pulmonary Fibrosis that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 80 participants, below the 885-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00258544, a study of Pulmonary Fibrosis, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is investigating the way the lung is damaged in a condition called pulmonary fibrosis. Research studies will be conducted on lung tissue obtained from an open lung biopsy performed by the subject's surgeon. The identification of unique genetic markers of scarred lung may ultimately lead to new approaches to the diagnosis and treatment of pulmonary fibrosis.
Primary Outcome
Microarray gene expression analysis involves the extraction of RNA from cells, synthesizing cDNA to hydridize to a probe array of genes, scanning signal intensities, and normalizing data to analyze probe-level expression for differential genes, Other methods of analyzing differential gene expression including Bulk RN-seq, and single cell RNA-seq will allow be employed where feasible.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2001-10 |
| Est. Completion | 2030-07 |
What the registry record for NCT00258544 still lists
NCT00258544 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 885-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Pulmonary Fibrosis appearing as the primary indexed condition, and to 0 interventions.
NCT00258544 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00258544 about?
NCT00258544 is a clinical study titled "Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)". This study is investigating the way the lung is damaged in a condition called pulmonary fibrosis. Research studies will be conducted on lung tissue obtained from an open lung biopsy performed by the subject's surgeon. The identification of unique genetic markers of scarred lung may ultimately lead t...
What is the current status of trial NCT00258544?
This trial is currently active not recruiting. The enrollment target is 80 participants. The study started on 2001-10. Estimated completion is 2030-07.
What conditions does trial NCT00258544 study?
This clinical trial studies the following conditions: Pulmonary Fibrosis.
Who is sponsoring clinical trial NCT00258544?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00258544 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00258544's enrollment target sits among peer trials
80 14th of 22 higher than 9 of 22 other Pulmonary Fibrosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Fibrosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Advanced Imaging for Pulmonary Fibrosis
RECRUITING · Phase 2
-
Pulmonary Fibrosis Foundation Community Registry
RECRUITING
-
Interstitial Lung Disease Research Unit Biobank
RECRUITING
-
FAPI PET for Lung Fibrosis
RECRUITING · Early Phase 1
-
Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
RECRUITING
-
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia